Efficacy and Safety of Insulin Glulisine in Type 1 Diabetes Mellitus
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
- To evaluate non-inferiority in the efficacy of HMR1964 as compared with Insulin lispro
in terms of the change in HbA1C from baseline to endpoint.
- To compare the safety of HMR1964 with insulin lispro.